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Cerebral palsy (CP) describes a group of disorders of the de‑
velopment of movement and posture that cause activity limitation, 
whichare attributed to non‑progressive disturbances that occur in 
the developing fetal or infant brain. The motor disorders of CP 
are often accompanied by disturbances of sensation, cognition, 
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ABSTRACT
Cerebral palsy (CP) is the leading cause of childhood disability affecting cognitive function and developments in approximately 
1.5 to 3 cases per 1000 live births. Based on Ayurvedic therapeutic principles, CP patients were subjected to Abhyanga (massage) with 
Moorchita Tila Taila (processed sesame oil) and Svedana (fomentation) with Shastikashali Pinda Sveda (fomentation with bolus of 
drugs prepared with boiled rice). Study group received Mustadi Rajayapana Basti (enema with herbal decoction) and Baladi Yoga 
(a poly‑herbo‑mineral formulation), while the placebo group received Godhuma Vati (tablet prepared with wheat powder) and saline 
water as enema. Treatment with Mustadi Rajayapana Basti and Baladi Yoga improved the activities of daily life by 8.79%, gross 
motor functions by 19.76%, and fine motor functions 15.05%, and mental functions like memory retention got improved by 15.43%. 
The placebo group showed an improvement of 0.21% in daily life activities, 2.8% in gross motor, and 2.4% in fine motor functions. 
Mustadi Rajayapana Basti and Baladi Yoga proved to be more supportive in improving the motor activities and gross behavioral 
pattern. Further clinical trials are required to evaluate and validate the maximum effect of the combination therapy in a large sample 
with repetition of the courses for longer duration.
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communication, perception, and/or behavior, and/or by a seizure 
disorder.[1] Incidence of CP ranges from 1.5 to 3 cases per 1000 
live births.[2] The incidence is higher in males than in females; 
the Surveillance of Cerebral Palsy in Europe (SCPE) reports 
male to female ratio of 1.33:1.00.[3] The United Cerebral Palsy 
Foundation states that there are 800,000 children and adults in the 
United States with CP. The Centers for Disease Control estimates 
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that about 10,000 babies are born each year with CP.[4] Despite 
the non‑progressive character of CP, some children deteriorate in 
mobility‑related activities during childhood.[5] Spasticity is a dis‑
abling clinical symptom that is prevalent in those with CP.[6] The 
primary problems associated with spasticity are loss of balance, 
strength, and selective motor control of the muscles, and increased 
muscle tone which leads to problems such as fixed contractures 
and bony deformities that cause severe motor dysfunctionin pa‑
tients.[7‑10] Perinatal asphyxia accounts for between 6% and 8% of 
CP. Prenatal causes are responsible for approximately 75% of all 
CP cases, although it is impossible to determine the nature and 
the exact timing of the damage. Postnatal acquired CP ranges in 
incidence from 10% to 18%.[11]
Management of CP focuses on helping the individual to maxi‑
mize his or her potential by providing physical therapy to facilitate 
motor development and to enhance independence in motor skills, 
self‑care, play, and leisure activities.[12] Current interventions for 
CP include: Physical therapy to prevent the weakening or deterio‑
ration of muscles and for motor development; braces or orthotic 
devices to stretch spastic muscles, which can disrupt balance and 
normal motor development; occupational therapy to help develop 
daily living skills, such as feeding, dressing, or using the bathroom; 
speech therapy to help develop communication and language skills; 
behavioral therapy to promote socially appropriate behaviors; and 
surgery to treat severe cases of contractures of muscles that cause 
movement problems or placing a feeding tube in severe cases of 
swallowing problems and malnutrition.[13]
CP cannot be correlated with any single disease or condition 
mentioned in Ayurveda, as it is a multifactorial disease. However, 
considering the classification and the respective features of the 
types, CP may be stated as Janma Bala Pravritta Vyadhi (congeni‑
tal disorder). In some cases, it may also be due to the derangement 
of Doshas (bodily humors). Consequently, CP may also be consid‑
ered as Shiro Marmabhighata Vata Vyadhi (diseases caused due 
to injury to head), as Marmaghata (injury to vital organs) is one 
of the causes of Vata Vikara (disease of Vata, i.e. body humor). 
Ayurvedic classics have mentioned that derangement of bodily 
humors and/or injury to vital organs during formative stage, fetal 
life, delivery, and neonatal period produces symptoms like loss 
of activities, stammering, dumbness, and weakness, including 
mental derangement due to impairment of motor and sensory 
activities. The therapeutic management is done according to Vata 
Vikara (disease of Vata, i.e. body humor) where the main line of 
treatment is considered to be application of medicated enema and 
internal administration of drugs.[14,15]
Incidence of CP has not declined despite the medical advances 
made in neonatal management and obstetric care. On the contrary, 
with a decline in infant mortality rate, there has actually been an 
increase in the incidence and severity of CP.[16] Defining the goals 
of CP treatment is one of the main issues in its management. These 
goals, which should be individualized for each patient, are to re‑
duce the muscle tone, increase the range of motion of the joints, 
improve the function of upper and lower extremities, delay the 
need for surgery, and predict surgical results.[2] The few available 
treatments to reduce generalized spasticity are associated with 
a high incidence of adverse effects and complications. There is 
an urgent need for studies to establish the efficacy of the current 
therapies and to find additional safe and effective treatments to 
help children affected by generalized spasticity due to CP. None 
of the oral medications used to treat spasticity in children has been 
adequately tested for safety and efficacy. There are minimal or no 
data regarding the pharmacokinetics or appropriate dosing param‑
eters to treat children.[17] These critical questions deserve serious 
research efforts. Currently there is no curefor CP.[18] Few answers 
can be found in various indigenous systems of medicines being 
used globally. Indian Systems of Medicine, including Ayurveda, 
Unani, and Siddha, have been in use since time immemorial and 
are time tested. The present study was conducted with a goal to 
improve physical activity, capacity of mobility, social participation, 
and health‑related quality of life in children with CP by means of 
Ayurvedic intervention using a combination of massage therapy, 
fomentation, and Ayurvedic drug administration through enema 
and oral route, i.e. Rajayapana Basti and Baladi Yoga.
MATERIALS AND METHODS
Design
This study had a double‑arm pre‑test and post‑test design.
Participants
Patients presenting with CP were enrolledfrom Kaumarab‑
hritya (Ayurvedic Pediatrics) out‑patient department and in‑patient 
department of SDM College of Ayurveda and Hospital, Hassan, 
irrespective of their sex, caste, religion, etc., Institutional ethical 
committee approved the protocol and written informed consent 
was obtained from the parents before any study‑related procedures 
were performed. The inclusion criteria were: (a) Patients diagnosed 
with CP; (b) patients of both sexes belonging to the age group 
of 2‑10 years. The exclusion criteria taken into account were: 
(a) presence of uncontrolled seizures and (b) systemic diseases 
such as renal or cardiac disorders.
Study drugs
1.  Mustadi Rajayapana Basti: Musta (Cyperus rotundas Linn.), 
Usheera [Vetiveria zizanioides (Linn.) Nash], Patha (Cissampe-
los pareiraLinn.), Amrita [Tinospora cordifolia (Thunb.) Miers], 
Tikta (Picrorhiza kurroa Royle ex Benth), Aragwadha (Cassia 
fistula Linn.), Bala (Sida cordifolia Linn.), Rasna (Alpinia of-
ficinarum Hance), Punarnava (Boerhavia diffusa Linn.), Man‑
jistha (Rubia cordifolia Linn. sensu Hook. f.), Brihati (Solanum 
indicum Linn.), Gokshura (Tribulus terrestris Linn.), Shala‑
parni [Desmodium gangeticum (Linn.) DC.], Prisniparni [Uraria 
picta (Jacq.) DC.], Kantakari (Solanum xanthocarpum Schrad. 
and Wendl.), Madanaphala [Randia dumetorum (Retz.) Poiret], 
Trayaman (Gentiana kurroo Royle), Satapuspa (Anethum sowa 
Kurz.), Yastimadhu (Glycyrrhiza glabra Linn.), Priyangu (Cal-
licarpa macrophylla Vahl.), Kutaja (Holarrhena antidysenterica 
Wall.), Daruharidra (Berberis aristata DC.), Saidhava Lava‑
na (Himalayan pink rock salt), Madhu (honey), Ghrita (butter 
oil), Ksheera (cow’s milk), Mamsa rasa (goat meat soup).
2.  Baladi Yoga: Bala (Sida cordifolia Linn.), Prasarani (Paede-
ria foetida Linn.), Eranda Mula (Ricinus communis Linn.), 
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Ashwagandha (Withania somnifera Dunal), Lashuna (Al-
lium sativum L.), Kumari [Aloe vera (L.) Burm. f.], Man‑
dukaparni [Centella asiatica (Linn.) Urban], Shuddha Ra‑
saka [purified zinc carbonate (ZnCO3)], Shuddha Mandura 
[purified iron silicate (Fe2SiO4)], Abhraka Bhasma [purified 
powdered talc, Biotite Calx].
3.  Godhuma Vati (placebo): Wheat powder processed and prepared 
in tablet form.
4. Sterilized saline water (placebo).
Raw drugs were procured from SDM Pharmacy, Udupi and 
were authenticated at Department of Dravyaguna and Vaisajya 
Kalpana, SDM College of Ayurveda and Hospital, Hassan.
Observation‑based assessment criteria
Assessment of the participants was madeaccording to the 
assessment criteria shown in Table 1, which were developed 
by the authors and a precise version can be found elsewhere.[15] 
However, the present work presents the augmented version of the 
assessment criteria.
Intervention
A total of 123 patients were registered within the study pe‑
riod of 24 months. The patients were randomly divided into two 
groups as follows: 61 patients in the study group, and 62 patients 
in control group who received placebo. Out of 123 participants, 
100 completed the study and 23 participants discontinued and 
Table 1. Assessment criteria for cerebral palsy patients
Daily activities Grade
Eating Totally dependent
Drinking Can do with physical support 0
Brushing Can do with verbal prompting 1
Bathing Can do independently 2
Toileting 3
Gross motor
Crawls a distance of 5ft or more Cannot do at all 0
Sitting Can do with support 1
Standing Can do without support 2
Walk for minimum 5‑10 steps Can do independently 3
Claps hands
Fine motor
Puts small object into a container Not does at all 0
Throws ball in any direction Does with help 1
Uses thumb and index finger Does independently 2
Retains two 1‑inch cubes in one hand for 30 s
Folds paper and inserts into envelope
Language
Ability to understand verbal commands No response 0
Turns face but not understanding 1
Understands but not acting accordingly 2
Understands and acts accordingly 3
Speech No speech and sound 0
Pronounces sound without meaning 1
Pronounces some words with meaning 2
Cannot make well‑formed sentences 3
Can speak well‑formed sentences 4
Performance
Making a triangle between three points Cannot draw at all 0
Can meet two points, not triangle 1
Can draw a triangle 2
Mental status
Happiness Never laughs or enjoys in social events 0
Occasionally laughs or enjoys in social events 1
Normally laughs or enjoys in social events 2
Memory (after showing five familiar objects) Cannot recollect any one of the objects shown 0
Can recollect some of the objects, but forgets 
the order
1
Can recollect five objects in the same order 2
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could not be followed up. Thus, 60 participants in the study group 
and 40 participants in the control group were followed up in this 
study. For 8 days, all the patients were given Abhyanga (total 
body massage) with Moorchita Tila Taila (processed sesame oil), 
followed by Svedana (fomentation) with Shastikashali Pinda 
Sveda. After that, Basti (enema) was administered according to 
the following regimen.
Group A – Study group (Mustadi Rajayapana Basti and Baladi 
Yoga): Mustadi Rajayapana Basti was administered once daily in 
the morning in empty stomach. After completion of Basti (enema) 
procedure, the patients were administered the powder of Baladi 
Yoga orally in a dose of 1 g/day in two divided doses with ghee 
and honey before food for consecutive 60 days.
Group B – Control group [Basti with saline water and God-
huma Vati (wheat powder)]: Basti was administered with saline 
water once daily in the morning in empty stomach. Thereafter, the 
participants were given one Godhuma Vati of 1 g in two divided 
doses for 60 days.
The participants were administered Basti in empty stomach 
to facilitate absorption of the drugs and bypass the first‑pass me‑
tabolism. The dose was administered as per the classical reference 
mentioned in Charaka Samhita (Siddhi Sthana 3:31‑32) and is 
shown in Table 2.
RESULTS
Sex wise distribution of the participants showed that group A 
consisted of 61.7% males and 38.3% females and group B con‑
sisted of 57.5% males and 42.5% females. Age wise distribution 
of the participants is shown in Table 3. Religion followed by the 
participants showed that 97% of the study participants belonged 
to Hindu religion, and 56% of the participants were from rural 
habitat. Occupation of the earning parents showed that 43% were 
primarily farmers, 27% had some kind of business setup, and 30% 
were service holders. It was noted that 31% of subjects belonged to 
joint family. In this series, an interesting fact came up, which was 
that 36% parents of the patients gave the history of consanguinity 
and 24% mothers have had early marriage and conception before 
the age of 18 years.
The pre‑conception status of the mothers showed on enquiry 
that 8% mothers of the patients had the history of spontaneous 
abortion, 2% mothers had undergone D and C operations, 2% used 
intrauterine contraceptive devices (IUCD), and 33% mothers had 
the history of using oral contraceptives. Accordingly, it was found 
that 45% mothers suffered from one or the other disease; of these, 
18% mothers had anemia, 12% had pre‑eclampsia, and 9% had 
pregnancy‑induced hypertension (PIH). However, 55% mothers 
remained healthy. Antenatal check‑up (ANC) reports showed that 
mothers of 52% children did not follow the ANC advices properly, 
while 36% properly followed them. On the other hand, the mothers 
of remaining 12% children did not attend ANC. Thirteen percent 
mothers delivered by Lower Uterine Cesarean Section and 6% 
delivered by instrumental application. Eighty‑one percent of the 
study subjects delivered within hospital setup. Among the 100 pa‑
tients, 55 were pre‑term infants. At the time of birth, 47% of the 
subjects had birth asphyxia and 44% were low‑birth‑weight babies 
with 44% subjected to incubation, while 43% subjects were born 
with abnormal head circumference. Effects of the intervention on 
daily activities andon the gross and fine motor functions assessed 
in both the groups, study and control, are shown in Tables 4‑6, 
respectively.
Significant improvement was observed in the study group 
regarding ability to understand verbal commands and intellect, 
speech, memory, and happiness, which is shown in Table 7. Overall 
improvement of 13.66% was seen in patients undergoing treatment 
with Mustadi Rajayapana Basti and Baladi Yoga, compared to 
2.21% improvement seen in the control group.
DISCUSSION
The results of the present study showed that Mustadi Rajay-
apana Basti along with Baladi Yoga provided mild improvement 
in 93.44% patients of the study group, with the outcome measures 
being mental status, fine and gross motor functions, and daily life 
activities. While in the placebo control group, Basti was admin‑
istered maintaining all the procedures, except that in the place 
of Mustadi Rajayapana Basti, only saline water was applied. In 
place of Baladi Yoga, Godhuma Vati (wheat powder) was admin‑
istered as placebo. These findings reveal that the beneficial effects 
observed were due to the medication also and not only due to the 
Basti (enema) procedure. The attendance of reasonable number 
of CP patients may be because 36% parents gave a history of 
consanguinity while 45% of the mothers were having some kind 
of complications before child birth. Early child birth was notice‑
able in 24% mothers. Studies worldwide have revealed that risk 
factors like pre‑existing diseases in mothers during delivery, birth 
asphyxia, gestational age, and low birth weight are associated with 
CP in children.[11] CP is a Vata Vyadhi; therefore, the therapies 
Table 2. Dosage of Basti (enema) according to age
Age (years) Dose of Basti 
classical (Pala)
Dose of Basti equivalent 






















% No. of 
patients
% No. of 
patients
%
2‑4 36 60 23 57.5 59 59
5‑7 21 35 14 35 35 35
8‑10 03 05 03 7.5 06 06
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having Brimhana (stoutening therapy) and Balya (strengthening) 
properties were selected for this thereby resulting in more circula‑
tion. Also, the venous and lymphatic return is assisted, increasing 
the strength (or immunity) of the body. It relieves pain in the joints, 
reduces emaciation of the study. Abhyanga and Shastikashali 
Pinda Sveda soothe the sensory nerve endings, thereby causing 
relaxation. They produce a hyperemic effect causing the arterioles 
to dilate, limbs, and make the body strong with well‑developed 
musculature. Abhyanga causes movements of the muscles, thereby 
accelerating the blood supply, which in turn helps in relieving the 
muscular fatigue and reduces stiffness. Mustadi Rajayapana Basti 
and Baladi Yoga have Rasayana (rejuvenator) effect in the body, 
Table 4. Effect of treatment (drugs andplacebo) with regard to assessment of daily activities in both the groups in this study (N=100)
Parameter Study group Control group
% improvement in relation to 
the pre‑interventional status
SD (±) P value % improvement in relation to 
the pre‑interventional status
SD (±) P value
Eating 10.76 0.43 <0.001 1.04 0.02 >0.10
Drinking 10.60 0.43 <0.001 0.00 0.00 >0.05
Brushing 9.15 0.42 <0.001 0.00 0.00 >0.05
Bathing 7.23 0.39 <0.001 0.00 0.00 >0.05
Toileting 6.25 0.38 <0.01 0.00 0.00 >0.05
SD: Standard deviation
Table 5. Effect of treatment (drugs andplacebo) on the gross motor functions in both the groups in this study (N=100)
Parameter Study group Control group
% improvement in relation to 
the pre‑interventional status
SD (±) P value % improvement in relation to 
the pre‑interventional status
SD (±) P value
Crawling 28.00 0.50 <0.001 5.00 0.26 >0.05
Sitting 30.85 0.50 <0.001 4.00 0.27 >0.05
Standing 15.00 0.46 <0.001 0.00 0.00 >0.05
Walking 09.52 0.42 <0.001 1.00 0.16 >0.10
Clapping hands 15.46 0.44 <0.001 4.00 0.27 >0.05
SD: Standard deviation
Table 6. Effect of treatment (drugs andplacebo) on thefine motor functions in both the groups in this study (N=100)
Parameter Study group Control group
% improvement in relation to 
the pre‑interventional status
SD (±) P value % improvement in relation to 
the pre‑interventional status
SD (±) P value
Puts small objects in 
a container
14.60 0.415 <0.001 2.00 0.158 >0.10
Throws ball in all 
directions
21.05 0.446 <0.001 6.00 0.350 >0.10
Uses thumb and 
index finger
11.36 0.376 <0.001 0.00 0.226 >0.05
Retains two 1‑inch 
cubes in one hand
17.78 0.446 <0.001 4.00 0.221 >0.10
Folds paper and 
inserts into envelope
10.48 0.390 <0.001 0.00 0.000 >0.05
SD: Standard deviation
Table 7. Effect of treatment (drugs andplacebo) on themental status in both the groups in this study (N=100)
Parameter Study group Control group
% improvement in relation to 
the pre‑interventional status
SD (±) P value % improvement in relation to 
the pre‑interventional status
SD (±) P value
Ability to understand verbal 
command and intellect
13.27 0.415 <0.001 1.00 0.158 >0.10
Speech 10.43 0.403 <0.001 2.00 0.221 >0.10
Performance 11.11 0.403 <0.001 3.00 0.221 >0.10
Memory 8.74 0.360 <0.01 3.00 0.221 >0.10
Happiness 21.05 0.450 <0.001 2.00 0.158 >0.10
SD: Standard deviation
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as Charaka had stated: Rasayana (rejuvenation therapy) Indriya 
Balam Param (increases the strength of sensory and motor organs), 
Visham Avisham Bhavati Gatre (removes toxins from the body 
parts), Medha Smriti Karam (promotes intellect and memory).[14] 
In this study, the role of Ayurvedic management has shown some 
hope for improving the quality of life among CP patients.
A study from USA showed that the massage therapy reduced 
spasticity and arm hypertonic muscle tone and improved fine and 
gross motor functioning in children with CP. Improved immune 
function has been reported in one massage study,[19] showing 
increased number and activity of natural killer cells, which have 
the potential to destroy viral cells.[20] Massage therapy has been 
shown to decrease stress hormone (cortisol) levels.[21] Several 
studies have reported that massage leads to enhanced alertness, 
as shownby increased cognitive scores in preschool children.[22] 
A study from Norway showed improvement in basic motor abili‑
ties and self‑care and mobility in young children with CP after 
they were given goal‑directed activity focused physiotherapy 
involving their local environment.[23] Treatment with botulinum 
toxin type A (BTX‑A) has been a well‑established option in the 
interdisciplinary management of spasticity since the late 1980s, 
providing focal reductions in muscle tone in CP patients. A study 
from Turkey highlighted that single multilevel BTX‑A injection 
reduces spasticity and improves motor function in children with 
CP.[2] Studies showed that for generalized spasticity, diazepam is 
probably effective in reducing spasticity, but there are insufficient 
data on its effect on motor function and its side‑effect profile. 
Tizanidine is possibly effective, but there are insufficient data 
on its effect on motor function and its side‑effect profile. There 
are insufficient data on the use of dantrolene, oral baclofen, and 
intrathecal baclofen, and toxicity has been frequently reported.[17] A 
survey in the USA showed 56% of the families of children with CP 
using Complementary and Alternative Medicine which included 
massage therapy and aqua therapy as the most common.[24] Recent 
years have also seen the development of multiple intensive therapy 
or educationally based programs which provide some benefits due 
to their strong focus on activity and independence, but also raise 
some concerns. These include the fact that they have failed to 
demonstrate superior effectiveness over other approaches. Despite 
their significantly greater time intensity, they fail to identify the 
“active” ingredients, making it unclear to determine which aspects 
of the programs are effective and which are not.[25]
Cure for CP is not yet available.[18] Throughout the lifespan of 
patients, the motor disability persists and interacts with normal 
developmental processes, altering its presentations and complica‑
tions. The present mode of care in CP includes regular physical 
therapy, followed by medical and surgical interventions if needed, 
mostly in early childhood through pre‑adolescence. A long list 
of treatments has shown to improve motor outcomes, but very 
few definite practical guidelines exist for the management of CP 
due to limited scientific evidence to support holistic intervention 
approaches. Consequently, approach toward CP patients varies 
among clinicians, health care settings, and geographic areas with 
regard to the different types and modes of treatments prescribed, 
the timing and the range of treatment intensity, or frequency of 
interventions. Since CP is a not a single disease entity with a known 
causal pathway, but in fact a heterogeneous group of disorders with 
etiological differences, brain injury patterns, and associated health 
complications, the choice and response to intervention is further 
complicated. Documentations reveal that the developmental 
patterns of children with CP are very slow, especially in physi‑
cal and cognitive disability. So, it is better to expect immediate 
short‑term effects of intervention rather than long‑term effects in 
reality. Instrument sensitivity to detect small changes in motor 
ability is another setback while studying the effects of treatment 
of motor problems resulting from CP. Even minor improvements 
have the potential of becoming major practical and psychologi‑
cal significance for children with CP and their families.[26] When 
Ayurvedic therapeutic principles were applied to CP patients, the 
patients showed signs of improvement, but in a very slow man‑
ner. Traditional Ayurvedic procedures have been used effectively 
since ages and were implemented for treating diseases related to 
congenital anomalies. However, knowledge‑based evidences need 
to be validated in a scientific way.
The increasing trend of Complementary and Alternative Medi‑
cine is reflective of the high interest in new and different therapies 
that has always been present among families of children with CP. 
The observations of this study are encouraging with rays of hope 
bestowed upon by the age‑old system of medicine of Ayurveda for 
the crippled children to have meaningful and improved quality of 
life. It is hoped that it will stimulate the research workers in the 
field to take up more such studies, so that new horizon may open 
up for children suffering from CP who are otherwise leading a 
long miserable life for no fault of their own. Further clinical trials 
must be carried out to evaluate and validate the maximum effect 
of Rajayapana Basti and Baladi Yoga combination, used in the 
present study, on a large sample with repetition of the courses for 
longer duration. Also, there is a need to find if by starting treat‑
ment in the early stage, i.e. immediately after cerebral injury and 
diagnosis, one can expect better improvement. Ayurveda with its 
immense treasure can deliver different modalities of treatment 
regarding CP. So, we have to explore these areas keeping in mind 
that a multi‑dimensional approach with evidence‑based personal‑
ized medicine will lead the road toward success.
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